Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas
dc.authorid | Olmezoglu, Ali/0000-0002-7809-9819 | |
dc.authorwosid | Olmezoglu, Ali/M-7932-2017 | |
dc.contributor.author | Ekici, Kemal | |
dc.contributor.author | Ozsekee, Naciye | |
dc.contributor.author | Mayadagli, Alpaslan | |
dc.contributor.author | Kocak, Mihriban Erdogan | |
dc.contributor.author | Olmezoglu, Ali | |
dc.date.accessioned | 2024-08-04T20:40:02Z | |
dc.date.available | 2024-08-04T20:40:02Z | |
dc.date.issued | 2014 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Purpose: To evaluate the efficacy and toxicity of CyberKnife stereotactic radiotherapy (SRT) for recurrent glial tumors previously treated with high-dose radiotherapy. Methods: CyberKnife SRT was performed in 37 patients with recurrent glial tumors who presented to our hospital between January 2007 and March 2012. The patients were subjected to a dose ranging from 20 to 28 Gy using the CyberKnife system with an average of two fractions. The median follow-up duration after SRT was 14 months (range 1.8-57). Results: The median survival time of the patients after recurrence was 22.3 months (95% confidence interval/95% Cl 12.5-32). The median survival times of the high- and low-grade patients were 29 and 19 months, respectively. No significant toxicity due to radiation was noticed during the follow-up period. No factor influencing mortality was found in either the univari ate or multivariate analysis.. Conclusion: SRT using CyberKnife is an effective and safe treatment choice for recurrent glial tumors. SRT achieves a more favorable outcome in the treatment of recurrent tumors, particularly in high-grade ones | en_US |
dc.identifier.endpage | 1034 | en_US |
dc.identifier.issn | 1107-0625 | |
dc.identifier.issn | 2241-6293 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 25536612 | en_US |
dc.identifier.scopus | 2-s2.0-84921895244 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1029 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/96668 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000347742000026 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Imprimatur Publications | en_US |
dc.relation.ispartof | Journal of Buon | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | CyberKnife | en_US |
dc.subject | glial tumors | en_US |
dc.subject | recurrence | en_US |
dc.subject | stereotactic radiosurgery | en_US |
dc.title | Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas | en_US |
dc.type | Article | en_US |